This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Centers for Disease Control and Prevention is seeking public comments on how Americans with chronicpain are successfully treating their symptoms. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.”
The Centers for Disease Control and Prevention is still seeking public comments on how Americans with chronicpain are successfully treating their symptoms. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
Those suffering from chronicpain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy.
Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse. ”
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”
In adults with chronicpain , what are the harms of Kratom or other plant-based substances for treatment of chronicpain? In adults with chronicpain, what are the harms of cannabinoids? In adults with chronicpain, what are the benefits of cannabinoids? A Statement from the AHRQ.
Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.
According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017. In the first study , Canadian researchers assessed the relationship between cannabis and benzodiazepines in a cohort of 146 patients enrolled in the nation’s medical marijuana access program.
As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Men were more likely than women to treat pain with cannabis.
They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients. Cannabis is currently used to treat a wide range of conditions.
This data aligns with Americans’ rising acceptance of cannabis. Policies like telemedicine, curbside pickup, and cannabis delivery made marijuana products more accessible and affordable to countless Americans. million patients in 2022, a sharp increase from the 3.1 The study also analyzed peoples’ reasons for registering.
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronicpain, nausea, seizures, and other medical conditions.
That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronicpain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronicpain. About RYAH Group, Inc. RYAH Group, Inc.
The participants also reported that medical marijuana has been beneficial for their various health conditions, which include chronicpain, anxiety, and insomnia. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.
Codeine works by binding to opioid receptors in the brain, blocking pain signals and providing a sense of relief. Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronicpain.
Despite the traumatic brain injury, chronicpain, and years of PTSD, Otha Smith considers himself one of the lucky ones. Years later, when medical cannabis was legalized in Maryland , where he lives, Smith told The Cannigma how he suddenly had access to a whole world of weed he had never encountered with his old dealer.
The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Medical cannabis is a safer alternative to the conventional opiate solutions and other pain management treatments. About LYPHE GROUP.
The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.
Data suggests that cannabis can be helpful for women with difficulties or dysfunction attaining orgasm. Endometriosis This is a condition in which tissue similar to the uterine lining grows outside the uterus, which can result in severe pain, scarring, and infertility. There may be a wide variety of causes for this syndrome.
If you’re dealing with a lack of sleep from an overactive mind, anxiety, or chronicpain, weed strains with sedating, anti-anxiety, and pain-relieving properties may be able to help you get the shut eye you deserve. Below are recommendations mostly based on extrapolated animal data and studies on essential oils from plants.
One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them. All of that data is packaged into software doctors can use to manage their patients’ medical marijuana treatment. “I I know how to collect data. I know how to analyze data.
Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. Qualifying conditions include anxiety disorders, severe chronicpain and epilepsy. It’s a very significant case,” Melewsky told Spotlight PA. “And
She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to ChronicPain. I don’t know that it’s a direct sleep agent, but when you are having less anxiety and less pain you likely will fall asleep a little bit easier and maybe sleep better.
With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”. Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry.
The research was published in the journal PLOS One – the name of the study is Frequency of cannabis and illicit opioid use among people who use drugs and report chronicpain: A longitudinal analysis. For the study researchers “included data from people in 2 prospective cohorts. Methods and findings. Conclusions.
This impressive group represents well-known leaders in the psychedelic and addiction fields and will help usher in a greater understanding of the science and data behind what we expect to be the most effective treatments for many mental health conditions ever available.”. About Delic Corp, Inc.
One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. One potential consequence of the FSA’s drive to rein in the UK’s CBD industry is reduced access to the previously available wide range of products.
According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. For too long, America has relied too heavily on opioids for pain relief. A Better Alternative for ChronicPain. The Opioid Problem.
Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Let’s find out. . Combat-Related PTSD is Slightly Different From PTSD .
I have successfully reduced 85% of my opioid use for chronicpain as the result of arthritis through several surgeries and medical cannabis. CFAMM’s goal is to support medical cannabis patients, improve their outcomes and enable them to obtain fair and safe access to their medication. million medical cannabis patients in Canada.
According to official data cited by the Czech News Agency (CTK), the treatment helped improve the health condition and well-being of patients in 69% of cases. In comparison, about 450 patients were prescribed a total of less than 5 kg of cannabis for therapeutic purposes in 2018.
New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. These include safer routes of administration, greater certainty of access, and better communication between patients and doctors.
Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. Shedding Stigma and Promoting Patient Access. Patient access also hinges on a doctor’s preconceived notions of cannabis.
Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .
A recently released Canadian study has found that authorizations to use medical cannabis for chronicpain patients correlated to a reduction in opioid use among those to whom they are prescribed. An analysis of the data found that medical cannabis authorization had mixed results on short-term opioid use. View original article.
Researchers collected data from the 2019-2020 National Health and Resilience in Veterans Study, a national survey that asks veterans to self-report their physical and mental health as well as their recent substance use. An analysis of the survey data revealed that 11.9 percent of veterans had used cannabis within the past six months.
The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. Chronicpain. One of the most widespread uses of medical marijuana is for chronicpain.
They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. It seems as though research on cannabis and cannabinoids is taking such large strides that it even surpasses research growth in other fields.
Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content